Disease/Infection News

RSS

Virus-like particles reveal unexpected mechanism for increased fitness and spread of SARS-CoV-2

Researchers in the United States have developed a new model for testing mutations in the four structural proteins of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

9 Aug 2021

New phylogenomic platform identifies increased recombination rates in SARS-CoV-2

Researchers in the United States, Australia and the UK have developed a novel method that enables the evolutionary ancestry (phylogeny) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to be comprehensively searched for recombinant lineages.

8 Aug 2021

High rates of COVID-19 vaccine motivation among Latinx parents – a single center study

A new study demonstrates high motivation among Latinx parents to get their children vaccinated against COVID-19.

8 Aug 2021

Long COVID may be due to persistent immune disturbances

A new study discusses abnormalities in the immune response following COVID-19 in samples collected from patients who have recovered from COVID-19.

8 Aug 2021

New study describes SARS-CoV-2 ExoN enzyme that promotes antiviral resistance

A new study describes the structure of a crucial enzyme present in SARS-CoV-2.

8 Aug 2021

First data-driven deep learning model can predict COVID-19 outbreak two weeks in advance

People's social behavior, reflected in their mobility data, is providing scientists with a way to forecast the spread of COVID-19 nationwide at the county level.

8 Aug 2021

New tabletop device can quickly detect SARS-CoV-2 from saliva samples

Engineers at MIT and Harvard University have designed a small tabletop device that can detect SARS-CoV-2 from a saliva sample in about an hour.

6 Aug 2021

COVID-19 vaccines offer better protection than natural immunity from prior infections

In today's MMWR, a study of COVID-19 infections in Kentucky among people who were previously infected with SAR-CoV-2 shows that unvaccinated individuals are more than twice as likely to be reinfected with COVID-19 than those who were fully vaccinated after initially contracting the virus.

6 Aug 2021

New CRISPR-based diagnostic test detects COVID-19 variants from saliva samples

With the Delta variant wreaking havoc on unvaccinated populations and COVID-19 cases spiking around the world, the pandemic is far from over.

6 Aug 2021

Science academies offer recommendations to improve pandemic preparedness in the future

In the run-up to the summit of the G20 states on October 30 and 31, 2021, in Rome/Italy, the science academies of these countries (Science20 Dialogue), including the German National Academy of Sciences Leopoldina, have published the joint statement "Pandemic preparedness and the role of science".

6 Aug 2021

Clarity on covid count: Pandemic’s toll on seniors extended well beyond nursing homes

As covid-19 resurges across the country, driven by the highly infectious delta variant, experts are extending our understanding of the pandemic's toll on older adults — the age group hit hardest by the pandemic.

6 Aug 2021

Pfizer/BioNTech COVID-19 vaccine offers decreased protection six months after second dose, suggests Israeli study

A recent study published on the preprint server medRxiv* determines whether the time elapsed since the second dose of the BNT162b2 vaccine is associated with an increased risk of breakthrough SARS-CoV-2 infection.

6 Aug 2021

SARS-CoV-2 Beta variant associated with more critical and fatal disease than Alpha, suggests Qatar study

A new study traces the degree to which the Beta variant of this virus is associated with severe, critical or fatal disease, using a case-control model.

6 Aug 2021

Study reports on COVID-19 vaccine-related adverse events in young Japanese population

A new study from Japan, released as a medRxiv* preprint, describes the adverse effects associated with the vaccine. Such data is crucial in delineating the safety and efficacy of this intervention in various age groups.

6 Aug 2021

Affinity maturation of SARS-CoV-2 antibodies make them more powerful and resistant to escape mutations

A new study in the journal Immunity shows in fascinating detail how antibodies elicited by this virus show affinity maturation, a process occurring by somatic hypermutation (SHM) in the lymphoid germinal centers, to become more specific in their recognition of antigens.

6 Aug 2021

Double vaccinated three times less likely to test positive for COVID-19 than unvaccinated, says study

In new research, scientists at Imperial College London report that double vaccinated individuals could be three times less likely than unvaccinated people to test positive for SARS-CoV-2 infection.

6 Aug 2021

Simplified glycan modeling of the SARS-CoV-2 spike protein

In a research paper recently uploaded to the preprint server bioRxiv* by Gecht et al. (August 4th, 2021), a new method of representing glycan conformers on static protein structures is explored, named GlycoSHIELD.

6 Aug 2021

Full dose anticoagulation with heparin improves outcomes for moderately ill COVID-19 patients

Collaborative international clinical trials testing full dose anticoagulation with heparin (a blood thinner) in both moderately ill and critically ill patients has found the treatment improves outcomes and reduces the need for vital organ support such as mechanical ventilation in moderately ill patients.

6 Aug 2021

Dialysis patients' response to COVID19 vaccine type

The researchers at Standford University evaluated the humoral vaccination response of 2,099 fully vaccinated patients undergoing dialysis.

5 Aug 2021

Multivalent nanobodies show improved neutralization activity against SARS-CoV-2

A state-of-the-art engineering approach toward improving the neutralizing activity of a cross-reactive nanobody, previously generated against the original SARS virus, showed it can be an attractive and viable option against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The study is published in the journal Advanced Therapeutics.

5 Aug 2021

Disease/Infection News

Virus-like particles reveal unexpected mechanism for increased fitness and spread of SARS-CoV-2

New phylogenomic platform identifies increased recombination rates in SARS-CoV-2

High rates of COVID-19 vaccine motivation among Latinx parents – a single center study

Long COVID may be due to persistent immune disturbances

New study describes SARS-CoV-2 ExoN enzyme that promotes antiviral resistance

First data-driven deep learning model can predict COVID-19 outbreak two weeks in advance

New tabletop device can quickly detect SARS-CoV-2 from saliva samples

COVID-19 vaccines offer better protection than natural immunity from prior infections

New CRISPR-based diagnostic test detects COVID-19 variants from saliva samples

Science academies offer recommendations to improve pandemic preparedness in the future

Clarity on covid count: Pandemic’s toll on seniors extended well beyond nursing homes

Pfizer/BioNTech COVID-19 vaccine offers decreased protection six months after second dose, suggests Israeli study

SARS-CoV-2 Beta variant associated with more critical and fatal disease than Alpha, suggests Qatar study

Study reports on COVID-19 vaccine-related adverse events in young Japanese population

Affinity maturation of SARS-CoV-2 antibodies make them more powerful and resistant to escape mutations

Double vaccinated three times less likely to test positive for COVID-19 than unvaccinated, says study

Simplified glycan modeling of the SARS-CoV-2 spike protein

Full dose anticoagulation with heparin improves outcomes for moderately ill COVID-19 patients

Dialysis patients' response to COVID19 vaccine type

Multivalent nanobodies show improved neutralization activity against SARS-CoV-2

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News